These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1719624)

  • 1. Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin.
    Uldry PA; Bogousslavsky J; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):301-5. PubMed ID: 1719624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Urtasun M; López de Munain A; Carrera N; Martí-Massó JF; López de Dicastillo G; Mozo C
    Ann Pharmacother; 1992 Jan; 26(1):32-3. PubMed ID: 1606342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose immunoglobulin therapy for childhood Guillain-Barré syndrome.
    Zafeiriou DI; Kontopoulos EE; Katzos GS; Gombakis NP; Kanakoudi FG
    Brain Dev; 1997 Jul; 19(5):323-5. PubMed ID: 9253484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].
    Hartung HP; Gold R; Zielasek J; Archelos JJ; Toyka KV
    Nervenarzt; 1994 Dec; 65(12):807-18. PubMed ID: 7854501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Guillain-Barré syndrome treated with intravenous high doses of immunoglobulins].
    Mauro G
    Rev Neurol (Paris); 1989; 145(10):731-2. PubMed ID: 2510231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins i.v.: a new approach to the treatment of Guillain-Barré syndrome.
    Fasanaro AM; Pizza V; Rossi V
    Minerva Med; 1996; 87(1-2):17-20. PubMed ID: 8610020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
    Notarangelo LD; Duse M; Tiberti S; Guarneri B; Brunori A; Negrini A; Ugazio AG
    Eur J Pediatr; 1993 Apr; 152(4):372-4. PubMed ID: 8482293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barré syndrome in children treated with intravenous immunoglobulin].
    Andersen UM
    Ugeskr Laeger; 1993 Oct; 155(42):3392-4. PubMed ID: 8259633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M; Assanta N; Chiaravalloti G; Rocopou C; Caiulo VA
    Minerva Pediatr; 1992 May; 44(5):237-40. PubMed ID: 1620076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M; Weinberger M
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group.
    Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.